非酒精性脂肪性肝病

非酒精性脂肪性肝病与胰岛素抵抗关系及超敏C反应蛋白在其临床分型上作用

Relationship between NAFLD and IR and The Role of hs-CRP in Clinical Classification of NAFLD

本研究证实甘氨酸可以通过拮抗内毒素控制脂肪肝的发生发展，为非酒精性脂肪性肝病的预防和治疗提供了新的思路。

Gly is proved to be the effective antagonists for endotoxin in this study which provided something new for the prevention and therapy of NAFLD .

e抗原阴性慢性乙型肝炎合并非酒精性脂肪性肝病的病理特征

Study on pathological characteristic in HBeAg negative chronic hepatitis B patients with nonalcoholic fatty liver disease

HPLC法比较非酒精性脂肪性肝病患者和正常人血浆中维生素E含量

Compare the contents of vitamin E in healthy human plasma with the nonalcoholic fatty liver disease patients by HPLC

目的：观察肝凋亡细胞及活性核因子κB在非酒精性脂肪性肝病大鼠模型中的表达及其意义。

AIM : To investigate the expression and significance of hepatocyte apoptosis and activation of nuclear factor ( NF ) - κ B in rat models with nonalcoholic fatty liver disease .

目的：探讨非酒精性脂肪性肝病（Nonalcoholicfattyliverdisease，NAFLD）的相关因素，提高对NAFLD的认识。

Objectives : To investigate the relevant factors of nonalcoholic fatty liver disease ( NAFLD ), and to improve the cognition to NAFLD .

目的研究非酒精性脂肪性肝病（NAFLD）的临床与病理特征。

Objective To study the pathological and clinical features of nonalcoholic fatty liver disease ( NAFLD ) .

目的探讨健步走运动对非酒精性脂肪性肝病（NAFLD）患者血液生化指标的改善效果。

Objective : To observe the influences of aerobic exercise on some blood biochemistry index of NAFLD patients .

在发达国家，非酒精性脂肪性肝病（NAFLD）是一种很常见的慢性肝脏疾病。

Nonalcoholic fatty liver disease ( NAFLD ) is one of the most common liver diseases in affluent countries .

目的探讨二甲双胍治疗非酒精性脂肪性肝病（NAFLD）的效果及安全性。

Objective To investigate the efficacy and safety of the dimethylbiguanide in the treatment of non-alcoholic fatty liver disease ( NAFLD ) .

MEK抑制剂PD98059及黄芪提取液对大鼠非酒精性脂肪性肝病影响的研究

The Effects of MEK Inhibitor PD98059 、 Astragalus Membranaceus Extraction on Nonalcoholic Fatty Liver Disease in Rats

目的评价奥利司他结合低热卡饮食在治疗肥胖伴非酒精性脂肪性肝病（NAFLD）中的作用。

Objective To evaluate the efficacy and safety of orlistat combined with low calorie diet in the treatment of obesity with non-alcoholic fatty liver disease .

近年来，国内外学者对其在非酒精性脂肪性肝病（NAFLD）发生机制中的作用给予高度重视。

More and more attentions have been given to the roles of kupffer cell on the pathogenesis of nonalcoholic liver disease ( NAFLD ) recently .

而研究也已证实胰岛素抵抗是非酒精性脂肪性肝病（NAFLD）的病理生理基础。因此，脂联素与NAFLD密切相关。

Meanwhile researches indicate that insulin resistance is the pathophysiologic foundation of nonalcoholic fatty liver disease ( NAFLD ), Therefore adiponectin has close association with NAFLD .

与年龄、性别匹配的健康对照者相比，非酒精性脂肪性肝病患者（NAFLD）的果糖摄入量显著增多。

Fructose consumption is higher in individuals with nonalcoholic fatty liver disease ( NAFLD ) than in age-matched and body mass index ( BMI ) - matched controls .

PI-3K在非酒精性脂肪性肝病发病中作用的研究进展

Advances in research on the role of phosphatidylinositol-3 kinase in the pathogenesis of nonalcoholic fatty liver disease

目的：调查乌鲁木齐市公务员健康体检人群非酒精性脂肪性肝病（NAFLD）的患病率、相关生化指标、相关危险因素。

Objective : To investigate the prevalence , correlated biochemical indexes and major risk factors of nonalcoholic fatty liver disease ( NAFLD ) among civil servant examination receivers in Urumqi .

目的研究罗格列酮联合还原型谷胱甘肽对非酒精性脂肪性肝病（NAFLD）大鼠胰岛素以及胰岛素信号转导相关蛋白表达的影响。

Objective To investigate the effect of rosiglitazone and reduced glutathione on insulin signaling proteins in rats with nonalcoholic fatty liver disease ( NAFLD ) . Methods NAFLD rats were produced .

目的对照性分析非酒精性脂肪性肝病（NAFLD）临床特点，探讨海狗油ω-3多不饱和脂肪酸胶丸（海狗油）对NAFLD的治疗效果。

Objective To investigate the clinical characters of nonalcoholic fatty liver disease ( NAFLD ) and observe the effect of seal oil ω - 3 polyunsaturated fatty acid ( seal oil ) on patients with NAFLD .

非酒精性脂肪性肝病（NAFLD）发病率逐年增加，非酒精性脂肪性肝炎（NASH）是其向肝硬化、肝功能衰竭发展的重要环节，已成为目前肝病领域的新挑战。

With the morbidity of non-alcohol fatty liver disease increasing year by year , NASH is critical in the development of liver fibrosis and liver failure , which has became a new challenge in the field of liver diseases research .

随着社会发展及生活方式的改变，非酒精性脂肪性肝病的发病率正在逐年增加，在我国，NAFLD已成为仅次于慢性病毒性肝炎的第二大肝病。

As the development of society and change of life style , the morbidity of NAFLD is increasing year by year . In our country , NAFLD has become the second bigger liver disease inferior only to viral hepatitis .

目的参照2005年NASH临床研究网络病理学会（NASH-CRN）评估方案，研究非酒精性脂肪性肝病（NAFLD）的病理特点。

Objective To summarize the pathological features of nonalcoholic fatty liver disease ( NAFLD ) in China based on a histological scoring system for NAFLD designed by the Pathology Committee of NASH Clinical Research Network ( NASH-CRN ) .

随着生活方式的改变，非酒精性脂肪性肝病（NAFLD）已成为许多发达和发展中国家日益增多的疾病，在我国的发病率也逐渐上升。

With the changes of life style , nonalcoholic fatty liver disease ( NAFLD ) has been on the increase and turns out to be an important disease in many developed and developing countries . In China , its incidence is gradually increasing too .

健步走对非酒精性脂肪性肝病患者血液生化指标的影响

Influences of Walking on Some Blood Biochemical Index of NAFLD Patients

成人非酒精性脂肪性肝病与代谢综合征关系

Relationship between nonalcoholic fatty liver disease and metabolic syndrome in adults

脂肪细胞因子在非酒精性脂肪性肝病中的作用

Roles of adipocytokines in the pathogenesis of non-alcoholic fatty liver disease

非酒精性脂肪性肝病致代谢异常

Non-alcoholic fatty liver disease promotes the development of metabolic abnormalities

血浆脂联素及瘦素水平在非酒精性脂肪性肝病的变化及意义

Relationship between plasma adiponectin and leptin levels with nonalcoholic fatty liver disease

水飞蓟素与左卡尼汀对非酒精性脂肪性肝病的临床研究

Clinical effect of silymarin combined with levocarnitine on non-alcoholic fatty liver disease

铁超负荷与非酒精性脂肪性肝病关系的研究进展

Relationship between iron overload and nonalcoholic fatty liver disease